Management Tracks: CRISPR, UK Research and Innovation

Gene editing company CRISPR Therapeutics AG (NASDAQ:CRSP) said Chief Legal Officer Tyler Dylan-Hyde will retire. The company hired Shelby Walker as head of IP. She was general counsel at Ginkgo Bioworks Inc. (Boston, Mass.).

UK Research and Innovation (Swindon, U.K.) appointed Melanie Welham as executive chair of the Biotechnology and Biological Sciences Research Council, for which she currently serves as interim chief executive. UKRI was created as part of the Higher Education and Research Act passed by Parliament in April 2017 and will officially launch next month...